Jeltsch M - Search Results

1

Lymphatic Vessels in Regenerative Medicine and Tissue Engineering.

Schaupper M, Jeltsch M, Rohringer S, Redl H, Holnthoner W. Schaupper M, et al. Among authors: jeltsch m. Tissue Eng Part B Rev. 2016 Oct;22(5):395-407. doi: 10.1089/ten.TEB.2016.0034. Epub 2016 Jun 27. Tissue Eng Part B Rev. 2016. PMID: 27142568 Review.

2

Genesis and pathogenesis of lymphatic vessels.

Jeltsch M, Tammela T, Alitalo K, Wilting J. Jeltsch M, et al. Cell Tissue Res. 2003 Oct;314(1):69-84. doi: 10.1007/s00441-003-0777-2. Epub 2003 Aug 27. Cell Tissue Res. 2003. PMID: 12942362 Review.

3

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.

Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K. Karkkainen MJ, et al. Among authors: jeltsch m. Nat Immunol. 2004 Jan;5(1):74-80. doi: 10.1038/ni1013. Epub 2003 Nov 23. Nat Immunol. 2004. PMID: 14634646

4

Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.

Tammela T, He Y, Lyytikkä J, Jeltsch M, Markkanen J, Pajusola K, Ylä-Herttuala S, Alitalo K. Tammela T, et al. Among authors: jeltsch m. Circ Res. 2007 May 25;100(10):1468-75. doi: 10.1161/01.RES.0000269043.51272.6d. Epub 2007 May 3. Circ Res. 2007. PMID: 17478733

5

Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization.

Tvorogov D, Anisimov A, Zheng W, Leppänen VM, Tammela T, Laurinavicius S, Holnthoner W, Heloterä H, Holopainen T, Jeltsch M, Kalkkinen N, Lankinen H, Ojala PM, Alitalo K. Tvorogov D, et al. Among authors: jeltsch m. Cancer Cell. 2010 Dec 14;18(6):630-40. doi: 10.1016/j.ccr.2010.11.001. Epub 2010 Dec 2. Cancer Cell. 2010. PMID: 21130043 Free article.

6

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.

Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. Jeltsch M, et al. Science. 1997 May 30;276(5317):1423-5. doi: 10.1126/science.276.5317.1423. Science. 1997. PMID: 9162011

7

Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts.

Dashkevich A, Raissadati A, Syrjälä SO, Zarkada G, Keränen MA, Tuuminen R, Krebs R, Anisimov A, Jeltsch M, Leppänen VM, Alitalo K, Nykänen AI, Lemström KB. Dashkevich A, et al. Among authors: jeltsch m. Am J Transplant. 2016 Apr;16(4):1160-72. doi: 10.1111/ajt.13564. Epub 2015 Dec 21. Am J Transplant. 2016. PMID: 26689983 Free article.

8

Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels.

Rauniyar K, Jha SK, Jeltsch M. Rauniyar K, et al. Among authors: jeltsch m. Front Bioeng Biotechnol. 2018 Feb 12;6:7. doi: 10.3389/fbioe.2018.00007. eCollection 2018. Front Bioeng Biotechnol. 2018. PMID: 29484295 Free PMC article. Review.

9

Key molecules in lymphatic development, function, and identification.

Jha SK, Rauniyar K, Jeltsch M. Jha SK, et al. Among authors: jeltsch m. Ann Anat. 2018 Sep;219:25-34. doi: 10.1016/j.aanat.2018.05.003. Epub 2018 May 26. Ann Anat. 2018. PMID: 29842991 Free article. Review.

10

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels.

He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T, Alitalo K. He Y, et al. Among authors: jeltsch m. Cancer Res. 2005 Jun 1;65(11):4739-46. doi: 10.1158/0008-5472.CAN-04-4576. Cancer Res. 2005. PMID: 15930292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page